IL6 and Sepsis: Additionally, LR12 treatment protected mice from sepsis-induced vascular dysfunction, measured by improved vascular contractility, and attenuated IL-6, TNF-α, and IL-10 expression as well as NOS and COX signaling pathway activation in murine aortas and mesenteric arteries (57).